Unchanged incidence and increased survival in children with neuroblastoma in Denmark 1981–2000: a population-based study
Authors:
Open Access
- 17 February 2009
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 100 (5) , 853-857
Abstract
Treatment results for neuroblastoma in Denmark have been poorer than in other Nordic countries, so we investigated whether a change in incidence, stage distribution and survival had occurred between 1981 and 2000. Clinical data were retrieved from the medical charts of 160 children n=139) or ganglioneuroblastoma (n=21) diagnosed in Denmark between 1981 and 2000. The minimal follow-up time was 52 months. Statistical analyses were performed in STATA. The incidence was 8.55 per million children below 15 years of age (world standard 9.6) and 42.6 per million children below 12 months of age, and it has remained unchanged since 1970. The median age at diagnosis was 27 months. In all, 32% of the children were aged below 12 months at diagnosis, 53% had metastatic disease and in 12% the diagnosis was made incidentally. Prognostic factors such as age, stage and site of primary tumour were the same as in other studies and did not change. During the study period, the mortality rate decreased steadily, and the 5-year survival rate increased from 38% in 1981–1985 to 59% in 1996–2000, corresponding to the level found in other Western countries. Increased survival was also seen in children with metastatic disease. Participation in international studies, better supportive care and possibly postoperative autologous stem cell transplantation may have contributed to the increased survival.Keywords
This publication has 18 references indexed in Scilit:
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialThe Lancet Oncology, 2008
- Neuroblastoma incidence and survival in European children (1978–1997): Report from the Automated Childhood Cancer Information System projectEuropean Journal of Cancer, 2006
- Long-term results and risk profiles of patients in five consecutive trials (1979–1997) with stage 4 neuroblastoma over 1 year of ageCancer Letters, 2003
- Neuroblastoma Screening at One Year of AgeNew England Journal of Medicine, 2002
- Survival of children with neuroblastomaEuropean Journal of Cancer, 2001
- Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: A report from the European Neuroblastoma Study Group ?Survey?Medical and Pediatric Oncology, 2001
- Neuroblastoma: Changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease RegistryMedical and Pediatric Oncology, 2001
- Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey’ 1982–1992European Journal of Cancer, 2000
- Neuroblastoma in Europe: differences in the pattern of disease in the UKThe Lancet, 1998
- Neuroblastomas in Denmark 1943-80. Epidemiological and Clinical StudiesActa Paediatrica, 1994